Leerink Partners analyst Stephen Tanal maintained a Buy rating on AdaptHealth (NASDAQ:AHCO) on Monday, setting a price target of $23.5, which is approximately 17.50% above the present share price of $20.
Tanal expects AdaptHealth to post earnings per share (EPS) of $0.00 for the third quarter of 2020.
The current consensus among 4 TipRanks analysts is for a Strong Buy rating of shares in AdaptHealth, with an average price target of $22.5.
The analysts price targets range from a high of $25 to a low of $20.
In its latest earnings report, released on 03/31/2020, the company reported a quarterly revenue of $191.44 million and a net profit of $9.31 million. The company's market cap is $1.79 billion.
According to TipRanks.com, Leerink Partners analyst Stephen Tanal is currently ranked with 1 stars on a 0-5 stars ranking scale, with an average return of -2.1% and a 46.81% success rate.
AdaptHealth Corp. provides medical products for both rental and sale. It focuses on respiratory and/or mobility equipment, including CPAP sleep equipment, oxygen equipment, wheelchairs, walkers, and hospital beds. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.